Importance of urinary interleukin-18 in intravesical immunotherapy with bacillus Calmette-Guérin for superficial bladder tumors

Pharmacology, Toxicology and Pharmaceutical Science

• Bacilli 100%
• Cytokine 72%
• Interleukin 18 36%
• Interferon 36%
• Immunotherapy 27%
• Interleukin 12 27%
• Interleukin 2 27%
• Carcinoma in Situ 27%
• Interleukin 4 18%
• Bladder Tumor 18%
• Recurrent Disease 9%
• Enzyme-Linked Immunosorbent Assay 9%
• Antitumor Activity 9%
• Bladder Carcinoma 9%
• Bladder Cancer 9%

Immunology and Microbiology

• Interleukin 18 36%
• Interferon Type I 27%
• Interleukin 2 27%
• Immunotherapy 27%
• Bladder 27%
• Interleukin 12 27%
• Urine 27%
• Interleukin 4 18%
• Natural Killer Cell 9%
• ELISA 9%
• Antineoplastic Activity 9%
• Interferon Production 9%

Neuroscience

• Interleukin 18 36%
• Interferon 27%
• Interleukin 2 27%
• Immunotherapy 27%
• Interleukin 12 27%
• Interleukin 4 18%
• Interferon Production 9%